Mary joined HealthTree as the HealthTree for MDS Program Manager in 2022. She is passionate about giving power to patients through knowledge and health education. If she can help one patient feel more confident participating in discussions with their healthcare team and making treatment decisions, she will feel like she has succeeded. When she isn't advocating for MDS patients, she loves being an aunt, attending concerts, and experimenting with new recipes in the kitchen.

Dr. Mikkael A. Sekeres joined the University of Miami Health System and Sylvester Comprehensive Cancer Center as Chief of the Division of Hematology. His research focuses on patients with myelodysplastic syndromes (MDS) and older adults with acute myeloid leukemia (AML). He has been the national and international primary study investigator on dozens of phase I/II/III clinical trials. He is the author or co-author of over 400 manuscripts and 600 meeting abstract. He is a frequent essayist for The New York Times and has written 8 books. He is on the Executive Committee of the American Society of Hematology and a member of the American Society of Clinical Oncology and the Southwest Oncology Group —Leukemia Committee.